Sixty per cent of people think politicians are not doing enough to improve care for older people according to a survey by Age Concern and Help the Aged. (Source: Alzheimers Society)MedWorm Message: Get the very latest Swine Flu news via the MedWorm Swine Flu RSS news feed - updated hourly from thousands of authoritative health and news sources.

Everyone has been there. You are about to get into an accident, your heart races, your mind is completely focused on the oncoming car, time seems to slow, your thoughts become crystal clear. It's a near-death experience that you never forget. Your "stress response" has helped you to survive.Here's another scenario: your boss is shouting at you, your kids are sick, bills are piling up, life is getting really stressful on a chronic basis, day after day, and... after a while, you can't think straight! Your mind is racing, you have trouble paying attention and focusing, memory is impaired, worries abound, you can't make decisions or you make bad decisions, and depression may set in. Now the "stress response" is impairing your brain.What's going on here??Let's go back to basic biology. Long ago...

Accera, Inc., a biotechnology company delivering breakthrough therapies in central nervous system diseases, announced data which showed that augmentation with ketone bodies significantly improved cognitive function in Alzheimer's disease (AD) patients. An early feature of AD is region specific declines in cerebral glucose metabolism. One strategy has been to supplement the brain's normal glucose supply with ketone bodies. The company's data was drawn from two clinical studies which examined the cognitive effects of induced ketosis... (Source: Health News from Medical News Today)

Accera, Inc., a biotechnology company delivering breakthrough therapies in central nervous system diseases, announced data which showed that augmentation with ketone bodies significantly improved cognitive function in Alzheimer's disease (AD) patients. An early feature of AD is region specific declines in cerebral glucose metabolism... (Source: Alzheimer's / Dementia News From Medical News Today)

We present these findings in protest of the way in which they were acquired.For more information: http://www.ncbi.nlm.nih.gov/pubmed/20085274 http://www.glaucoma.org/ http://www.nei.nih.gov/health/glaucoma/glaucoma_facts.asp (Source: NaturalNews.com)

(Source: Drugs)MedWorm Message: Get the very latest Swine Flu news via the MedWorm Swine Flu RSS news feed - updated hourly from thousands of authoritative health and news sources.

Conclusions and implications: Our data suggest that soluble A[beta]-treated rats have a depressive, but not anxiogenic-like, profile, accompanied by brain region-dependent alterations in the expression of neurotrophins and 5-hydroxytryptaminergic neurotransmission. Hence, these alterations induced by soluble A[beta] might be sensitive indicators of early phases of AD and possible risk factors for the expression of neuropsychiatric symptoms in AD. (Source: British Journal of Pharmacology)

Has medical science changed your life? Science: [So What? So everything] is a campaign that looks at what science is doing for us and how it will improve our future. (Source: Alzheimers Society)

Francisca Terrazas and other Latinas are about 1.5 times more likely than Anglos to develop Alzheimer's and other forms of dementia, a new report says. Read how her family copes. (Source: CNN.com - Health)

Blacks, Hispanics at much higher risk for the illness, which carries huge price tag, report finds Source: HealthDay Related MedlinePlus Pages: Alzheimer's Disease, Health Disparities (Source: MedlinePlus Health News)

WASHINGTON (MedPage Today) -- African Americans and Hispanics are much more likely than whites to develop Alzheimer’s disease and other dementias, according to new figures from the Alzheimer’s Association. (Source: MedPage Today Neurology)MedWorm Message: Get the very latest Swine Flu news via the MedWorm Swine Flu RSS news feed - updated hourly from thousands of authoritative health and news sources.

Minorities are at significantly higher risk for developing Alzheimer's disease, finds a new report from the Alzheimer's Association in the U.S. that has implications for minorities in Canada as well. (Source: CTV Health)

Social Security Commissioner Michael Astrue is the recipient of the Alzheimer's Association's 2010 Humanitarian Award. The award is given each year to a public official who has made a significant contribution to help those who are struggling with Alzheimer's disease... (Source: Alzheimer's / Dementia News From Medical News Today)

According to the Alzheimer's Association's® 2010 Alzheimer's Disease Facts and Figures, African-Americans are about two times more likely and Hispanics are about one and one-half times more likely than their white counterparts to have Alzheimer's and other dementias... (Source: Alzheimer's / Dementia News From Medical News Today)

Social Security Commissioner Michael Astrue is the recipient of the Alzheimer's Association's 2010 Humanitarian Award. The award is given each year to a public official who has made a significant contribution to help those who are struggling with Alzheimer's disease. This year, the award will be given to Commissioner Astrue in recognition of his exceptional leadership in creating the Compassionate Allowances Initiative and the decision to include early-onset Alzheimer's disease and other dementias in that initiative... (Source: Health News from Medical News Today)

According to the Alzheimer's Association's® 2010 Alzheimer's Disease Facts and Figures, African-Americans are about two times more likely and Hispanics are about one and one-half times more likely than their white counterparts to have Alzheimer's and other dementias. Although whites make up the great majority of the more than five million people with Alzheimer's and other dementias, African-Americans and Hispanics are at higher risk for developing the disease... (Source: Health News from Medical News Today)MedWorm Message: Get the very latest Swine Flu news via the MedWorm Swine Flu RSS news feed - updated hourly from thousands of authoritative health and news sources.

The Cinderella story eventually has a happy ending, but to revelers in the Dimebon story right now the time must feel like five past midnight. Some scientists have considered the sudden transformation of a modest hay fever medicine from Russia into the latest star in the AD drug development arena as a bit of a fairy tale all along. But it was hard for scientists and the media not to get swept up in the excitement over a young biotech company's $725 M dollar deal to develop Dimebon for a heart-breaking disease that has yet to see a truly effective treatment... (Source: Health News from Medical News Today)

The Cinderella story eventually has a happy ending, but to revelers in the Dimebon story right now the time must feel like five past midnight. Some scientists have considered the sudden transformation of a modest hay fever medicine from Russia into the latest star in the AD drug development arena as a bit of a fairy tale all along... (Source: Alzheimer's / Dementia News From Medical News Today)

Francisca Terrazas could not be left alone. (Source: CNN.com - Health)

Ophthalmologic abnormalities have been described in patients with dementia, but the extent to which poor vision and treatment for visual disorders affect cognitive decline is not well defined. Linked data from the Health and Retirement Study and Medicare files (1992–2005) were used to follow the experiences of 625 elderly US study participants with normal cognition at baseline. The outcome was a diagnosis of dementia, cognitively impaired but no dementia, or normal cognition. Poor vision was associated with development of dementia (P = 0.0048); individuals with very good or excellent vision at baseline had a 63% reduced risk of dementia (95% confidence interval (CI): 20, 82) over a mean follow-up period of 8.5 years. Participants with poorer vision who did not visit an ophthalmologis...